Graduate Periodontics Clinic, School of Dentistry, University of Louisville
Louisville, Kentucky, 40202, United States
NCT Number: NCT01902056
The purpose of this study is to compare the effect on soft tissue thickness of placing either a single or double layer of acellular dermal matrix simultaneous with dental implant placement. The hypothesis is that 2 layers of acellular dermal matrix will produce thicker tissues that one layer.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Louisville, Kentucky, 40202, United States
Patients must be greater that 18 years old, not pregnant, and have an edentulous space with a tooth on each side that is treatment planned to receive a dental implant. The primary outcome measure is soft tissue thickness.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The inclusion criteria were;
Exclusion criteria
The exclusion criteria included:
The acellular dermal matrix was placed on the facial surface.
Other names: One layer of acellular dermal matrix (Alloderm).
The acellular dermal matrix was placed on the facial surface.
Other names: Two layers of acellular dermal matrix (Alloderm).
Time frame: 4 months
Determining the soft tissue thickness using a tissue probe.
University of Louisville
Other
Implant Placement and Simultaneous Soft Tissue Grafting With Single or Double Layers of Acellular Dermal Matrix: A Randomized, Controlled Clinical Tria.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05867784
Clinical Efficacy, Crohn Disease
Wenzhou, Zhejiang, China
View Trial DetailsNCT02467946
Clinical Efficacy, Safety
Nice, France
View Trial DetailsNCT05144295
Chemically-Induced Disorders, Clinical Efficacy
Alexandria, Egypt
View Trial DetailsNCT01431131
Bone Diseases, Bone Resorption
Louisville, Kentucky, United States
View Trial Details